Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Headings will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Name, Email, Phone Room Group(s)/Office ID
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers 565
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers 2507
Hodges, Nick, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers 2276
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers 2301
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers 585
Mazurchuk, Richard, Ph.D.
richard.mazurchuk@nih.gov
240-276-7126
5E582 Program Officer | Cancer Biomarkers 587
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers 597
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Program Officer | Cancer Biomarkers 603
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers 653
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers 629
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers 639
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers 644

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Iyer, Prasad G.

Mayo Clinic Rochester
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 5R01CA241164-06 Matthew Young, Ph.D.
Justilien, Verline

Mayo Clinic Jacksonville
United States

ECT2 Isoform Switch in Pancreatic Cancer. 1R21CA296671-01 Matthew Young, Ph.D.
Kalluri, Raghu

University Of Tx Md Anderson Can Ctr
United States

Rigorous and reproducible mutational analysis of the urinary exosomal DNA 5R01CA231465-05 Matthew Young, Ph.D.
Kanwal, Fasiha

Baylor College Of Medicine
United States

Risk Stratification for and Early Detection of Liver Cancer 5U01CA230997-07 Sidney Fu, M.D.
Kibel, Adam S

Brigham And Women'S Hospital
United States

Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer 5U01CA268810-02 Richard Mazurchuk, Ph.D.
Kirkwood, Kimberly Saunders

University Of California, San Francisco
United States

Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer 1U01CA282269-01A1 Matthew Young, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

Multi-cancer Early Detection 2R01CA214679-08 Matthew Young, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation 5R37CA214679-07 Matthew Young, Ph.D.
Klein, Alison P

Johns Hopkins University
United States

Improving Management of patients at High Risk of Pancreatic Cancer 1R01CA299421-01 Matthew Young, Ph.D.
Kuhn, Peter

University Of Southern California
United States

Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma 5U01CA285013-02
Kuhs, Krystle A.

University Of Kentucky
United States

Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer 5R21CA267152-02 Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-03 Christos Patriotis, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 5R33CA281802-02 Wendy Wang, Ph.D., M.Sc.
Lampe, Paul D

Fred Hutchinson Cancer Center
United States

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer 5R01CA281801-02 Richard Mazurchuk, Ph.D.
Lee, Juhun

University Of Pittsburgh At Pittsburgh
United States

Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis 5R01CA269540-03 Sidney Fu, M.D.